HIGHLIGHTS OF PRESCRIBING INFORMATION
These highlights do not include all the information needed to use VFEND safely and effectively. See full prescribing information for VFEND.
VFEND® (voriconazole) tablets, for oral use
VFEND® (voriconazole) for oral suspension
VFEND® (voriconazole) for injection, for intravenous use
Initial U.S. Approval: 2002
RECENT MAJOR CHANGES
INDICATIONS AND USAGE
VFEND is an azole antifungal indicated for the treatment of adults and pediatric patients 2 years of age and older with:
DOSAGE AND ADMINISTRATION
DOSAGE FORMS AND STRENGTHS
WARNINGS AND PRECAUTIONS
To report SUSPECTED ADVERSE REACTIONS, contact Pfizer Inc. at 1-800-438-1985 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
USE IN SPECIFIC POPULATIONS
See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.